Mylife

Mylife is a well-established diabetes brand that has recently being licensed to the MTD Group. The brand extends to pen needles and blood glucose monitoring systems (BGMs) distinguished by its Swiss-made design and advanced technologies.

With a focus on innovative technology, mylife prioritizes ease of use and comfort, enhancing both blood glucose monitoring and insulin therapy administration. Its advanced technology not only simplifies diabetes management for patients but also ensures the safety of healthcare professionals (HCPs) and caregivers during medication administration.

MYLIFE

Pen Needles

This is the range of pen needles designed to provide comfortable, easy and safe drug administration. Through the development of innovative technologies, from the “6-bevel” and the “Click technology” to the “double protection”, the range offers solutions aimed at providing a gentle and safe injection experience for diabetes patients, caregivers and HCPs.

MYLIFE

Blood Glucose Monitoring Systems

The BGMs range features a selection of high-quality devices designed to help diabetes patients to monitor their blood glucose levels in an easy and intuitive way. These systems are engineered with user-friendly interfaces, making them intuitive and straightforward to use.